Related Experiment Video
Updated: Jul 30, 2026

10:54
Extraction of Plant-based Capsules for Microencapsulation Applications
Published on: November 9, 2016
Lupene-type triterpenes from Periploca aphylla
1International Center for Chemical Sciences, HEJ Research Institute of Chemistry, University of Karachi, Karachi-75270, Pakistan.
Journal of Natural Products
|June 28, 2000
Summary
Two new lupane derivatives were isolated from Periploca aphylla stems. Compound 1 demonstrated significant alpha-glucosidase inhibition and moderate antibacterial effects.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Periploca aphylla is a plant species known for its potential medicinal properties.
- Lupane derivatives are a class of triterpenoids with diverse biological activities.
- Natural products are a rich source of novel therapeutic compounds.
Purpose of the Study:
- To isolate and characterize new chemical compounds from Periploca aphylla stems.
- To evaluate the biological activities of the isolated compounds, specifically alpha-glucosidase inhibition and antibacterial effects.
Main Methods:
- Phytochemical investigation of Periploca aphylla stem extracts.
- Isolation of compounds using chromatographic techniques.
- Structure elucidation using spectroscopic methods (NMR, MS) and chemical derivatization.
- In vitro assays to assess alpha-glucosidase inhibitory activity.
- In vitro assays to determine antibacterial activity against selected bacterial strains.
Main Results:
- Two new lupane derivatives, 3beta,6alpha-dihydroxylup-20(29)-ene (1) and 6alpha-hydroxylup-20(29)-en-3beta-octadecanoate (2), were successfully isolated.
- The structures of compounds 1 and 2 were confirmed through comprehensive spectral and chemical analyses.
- Compound 1 exhibited potent inhibition against alpha-glucosidase type VI.
- Compound 1 displayed moderate antibacterial activity.
Conclusions:
- Periploca aphylla stems are a source of novel lupane-type triterpenoids.
- The isolated compound 3beta,6alpha-dihydroxylup-20(29)-ene shows promising potential as an alpha-glucosidase inhibitor.
- The findings suggest that Periploca aphylla derivatives warrant further investigation for therapeutic applications, particularly in managing conditions related to alpha-glucosidase activity and bacterial infections.

